Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of April 11, 2021
Seeking to expand targeted therapy for lung cancer
NIH MERIT Award will support Dr. Alice Berger’s efforts to target lung cancer-associated gene mutation
Omics made easier
To see the big picture, just add ‘ome’
Outlining the molecular networks that alter cell function and behavior
Dr. Taran Gujral’s NSF CAREER Award will allow him to study how cells shift to new functional states in normal development and disease
Grad student Emma Wrenn receives Weintraub Award
13 recipients of prestigious award selected for research originality, innovation
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news
Could bacterial enzymes drive cancer formation by directly modifying human DNA?
W.M. Keck Foundation grant will help scientists pioneer new technologies to find out
New awards to spur innovation, commercialization in life sciences research
Funding from Washington Research Foundation continues longstanding collaboration with Fred Hutch
Fearless Science is ...
Hutch researchers take bold approaches to solving hard problems
Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test
Antibody-drug conjugate could be step toward selective treatment for neuroendocrine prostate cancer
New regional collaborations will accelerate innovation in data-intensive medical science
Three research teams in Washington, Oregon and British Columbia receive pilot funding from Cascadia Data Alliance
MYCN drives the development of chemoresistance in small cell lung cancer
From the MacPherson lab, Human Biology Division
Seeking targeted treatments for pancreatic cancer
American Cancer Society fellowship to Dr. Nithya Kartha supports search for vulnerabilities in most aggressive pancreatic tumor subtype
Fred Hutch Evergreen Fund awards six grants to promising projects
Scientists receive up to $200K to boost research for projects deemed to have partnership potential
YAP1 gene fusions are oncogenic drivers in several tumor types and potential therapeutic targets
From the Holland, Paddison, Vasioukhin, and Gujral labs, Human Biology Division
Improved CRISPR-Cas9 delivery method allows for fast and precise knockouts
From the Paddison lab, Human Biology Division
'Everything we’ve been training for is happening now'
How early-career virologists dropped everything to seize the opportunity, and face the challenges, of studying the coronavirus
Stalled science, missed mates and virtual everything
Torn between science and safety concerns, young scientists navigate a new normal as they try to launch their careers
New insights into drug resistance in small cell lung cancer
Scientists discover a single gene’s outsized role in drug resistance — and use its vulnerability to re-sensitize tumors to chemotherapy in preclinical models
Can a tumor that acts like a microbe help us develop better cancer therapies?
Understanding the genetics underlying spontaneous regression of an infectious tumor in Tasmanian devils could point us toward new treatment targets
Shifting liver cancer cells away from migratory state could reduce their drug resistance
Researchers hope lab-based study helps build foundation for personalized treatment of hepatocellular carcinoma